Company Overview of CardioPharma, Inc.
CardioPharma, Inc., a specialty pharmaceutical company, develops combinatorial cardiovascular products. The company offers CardiaPil, a cardiovascular drug that comprises statin or cholesterol lowering agent; an ACE or antihypertensive agent; and ASA, an antiplatelet drug. Its pipeline products comprise drugs that target specific patient populations with cardiovascular disease. The company was founded in 2006 and is based in Wilmington, North Carolina.
100-A Eastwood Center Drive
Wilmington, NC 28403
Founded in 2006
Key Executives for CardioPharma, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact CardioPharma, Inc., please visit www.cardio-pharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.